Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review

von Etienne, A., Gruson, B., Chatelain, D., Garidi, R., Royer, B., Sevestre, H., Marolleau, J. P., Damaj, G.
Veröffentlicht 2009

Genomic organization of the mouse T cell receptor V alpha family.

von Jouvin-Marche, E, Hue, I, Marche, P N, Liebe-Gris, C, Marolleau, J P, Malissen, B, Cazenave, P A, Malissen, M
Veröffentlicht 1990

The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer

von Desgrandchamps, F, Teren, M, Cortivo, L Dal, Marolleau, J-P, Bertheau, P, Villette, J-M, Cortesse, A, Teillac, P, Duc, A Le, Hamdy, F C
Veröffentlicht 1999

Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone Lymphoma

von Schmidt-Tanguy, A., Houot, R., Lissandre, S., Abgrall, J. F., Casassus, P., Rodon, P., Desablens, B., Marolleau, J. P., Garidi, R., Lamy, T., Moles-Moreau, M.-P., Damaj, G.
Veröffentlicht 2014

High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study

von Cottu, P H, Extra, J M, Espie, M, Marolleau, J P, Roquancourt, A de, Makke, J, Miclea, J M, Laurence, V, Mayeur, D, Lerebours, F, Cuvier, C, Marty, M
Veröffentlicht 2001

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.

von Chabannon, C., Cornetta, K., Lotz, J. P., Rosenfeld, C., Shlomchik, M., Yanovitch, S., Marolleau, J. P., Sledge, G., Novakovitch, G., Srour, E. F., Burtness, B., Camerlo, J., Gravis, G., Lee-Fischer, J., Faucher, C., Chabbert, I., Krause, D., Maraninchi, D., Mills, B., Kunkel, L., Oldham, F., Blaise, D., Viens, P.
Veröffentlicht 1998

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

von Hunault-Berger, M, Maillard, N, Himberlin, C, Recher, C, Schmidt-Tanguy, A, Choufi, B, Bonmati, C, Carré, M, Couturier, M-A, Daguindau, E, Marolleau, J-P, Orsini-Piocelle, F, Delaunay, J, Tavernier, E, Lissandre, S, Ojeda-Uribe, M, Sanhes, L, Sutton, L, Banos, A, Fornecker, L M, Bernard, M, Bouscary, D, Saad, A, Puyade, M, Rouillé, V, Luquet, I, Béné, M C, Hamel, J-F, Dreyfus, F, Ifrah, N, Pigneux, A
Veröffentlicht in Blood Cancer J (2017)